Cargando…
552. Could Anticoagulant Use Prior to Infection with COVID-19 Decrease Mortality?
BACKGROUND: The novel coronavirus (COVID-19) has resulted in substantial morbidity and mortality worldwide. Infection with COVID-19 has been associated with coagulopathy and inflammation. This prothrombotic state has been identified in the literature as an indicator of poor prognosis and those with...
Autores principales: | Natali, Kayla M, Chan, Kok Hoe, Atallah, Liana, Nagarakanti, Sindhu, Slim, Jihad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777871/ http://dx.doi.org/10.1093/ofid/ofaa439.746 |
Ejemplares similares
-
361. A Case Control Study of COVID-19 Outcome in Patients with HIV
por: Atallah, Liana, et al.
Publicado: (2020) -
63. Prognosis of COVID-19 Patients with Diabetic Ketoacidosis with or Without Hyperosmolar Hyperglycemic State
por: Chan, Kok Hoe, et al.
Publicado: (2020) -
387. Markers for Mortality in COVID-19 Patients with Atrial Fibrillation or Flutter
por: Chan, Kok Hoe, et al.
Publicado: (2020) -
455. Diagnostic Value of Hematological Parameters in Different Stages of the Disease in Covid-19 Patients
por: Ali, Ruhma, et al.
Publicado: (2021) -
360. A Case Control Study of COVID-19 in Patients with End Stage Renal Disease (ESRD)
por: Lim, Su Lin, et al.
Publicado: (2020)